Advent of 3D Printed Devices and Development of Patient-Specific Implants to Proliferate Medical Polymer Industry | UnivDatos Market Insights

2022-09-24 02:29:40 By : Ms. Phoebe Pang

NOIDA, India , Sept. 21, 2022 /PRNewswire/ -- According to a new report published by UnivDatos Markets Insights, the Medical Polymer Market was valued around USD 16 billion in 2020 and is expected to grow at a CAGR of over 8% during 2021-2027. The analysis has been segmented into Type (Commodity Polymer, Engineering Polymer, and High-Performance Polymer); Structure (Amorphous and Crystalline); Application (Medical Disposables, Prosthetics, Medical Instruments & Tools, Drug Delivery, and Others); Region/Country.

Click here to view the Report Description & TOC

https://univdatos.com/report/medical-polymer-market/

The Medical Polymer market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the Medical Polymer market. The Medical Polymer market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the Medical Polymer market at the global and regional levels.

https://univdatos.com/get-a-free-sample-form-php/?product_id=24187

The demand for the medical polymer is increasing on account of the rising demand for advanced medical technology in implants, growing demand for artificial organs, smart inhalers, precision medicines, rising preference for the minimally invasive devices or surgical procedures and rise in the need for robotic assistance in surgical procedures. In the recent few years, the number of injuries due to accidents is also increasing which high demands the use of prosthetics products, further boosting the growth of the medical polymer market. As per the WHO 2021, around 1.3 million people die each year due to road traffic crashes and around 20 to 50 million more people suffer non-fatal injuries, with many experiencing a disability due to their injury. These medical plastics are highly used in prosthetics, providing a life-changing solution for physically disabled people. Further, rising investment in the healthcare sector in developing economies in order to improve the healthcare infrastructure and the rising geriatric population which are looking for safe and advanced procedures is likely to propel the market of medical polymer.

Click here to view the Report Description & TOC

https://univdatos.com/report/medical-polymer-market/

The global Medical Polymer market report is studied thoroughly with several aspects that would help stakeholders in making their decisions more curated.

Based on type, the market is categorized into commodity polymer, engineering polymer, and high-performance polymer. Among these, the high-performance polymer is likely to showcase robust growth owing to the increasing adoption of these polymers in prosthetics, medical devices, and drug delivery devices applications due to their resilience against a majority of body substances and are highly heat resistant and inert, thereby which makes them ideal for medical devices that come into direct contact with blood and tissue.

Based on structure, the market is categorized into amorphous and crystalline. Of both, crystalline is like to showcase a substantial share during the forecast period. This can be attributed to the presence of several high-performance polymers in this segment which are getting widespread acceptance in the healthcare industry for medical device and prosthetics applications like PEEK and PTFE.

Have a Look at the Chapters - https://univdatos.com/report/medical-polymer-market/

Medical Polymer Market Geographical Segmentation Includes:

North America (United States , Canada , and Rest of North America )

Europe (Germany , United Kingdom , Spain , Italy , France , and the Rest of Europe )

Asia-Pacific (China , Japan , India , Australia , and the Rest of Asia-Pacific )

North America accounted for a prominent share in the medical polymer market on account of the presence of a highly diversified medical devices market and it offers a wide range of products for the diagnosis and treatment of patients, ranging from medical catheters to implants and vascular grafts. Moreover, the high investment in R&D and the development of high-quality products using advanced technology are also expected to propel market growth. The innovations, for example, stent technologies, biomarkers, neuro-stimulators, robotic assistance, and implantable electronic devices in the medical device, further drive the market growth.  In November 2019 , Cardiology devices developer Baylis Medical has launched one of the smallest 2-French (2F) EPstar fixed electrophysiology catheters in the North American market to reach different areas of the heart to perform procedure mapping.

The major players targeting the market include

The degree of competition among prominent global companies has been elaborated by analyzing several leading key players operating worldwide. The specialist team of research analysts sheds light on various traits such as global market competition, market share, most recent industry advancements, innovative product launches, partnerships, mergers, or acquisitions by leading companies in the Medical Polymer Market. The major players have been analyzed by using research methodologies for getting insight views on global competition.

Key questions resolved through this analytical market research report include:

What are the latest trends, new patterns, and technological advancements in the Medical Polymer market?

Which factors are influencing the Medical Polymer market over the forecast period?

What are the global challenges, threats, and risks in the Medical Polymer market?

Which factors are propelling and restraining the Medical Polymer market?

What are the demanding global regions of the Medical Polymer market?

What will be the global market size in the upcoming years?

What are the crucial market acquisition strategies and policies applied by global companies?

We understand the requirement of different businesses, regions, and countries, we offer customized reports as per your requirements of business nature and geography. Please let us know If you have any custom needs.

Browse Other Related Research Reports from UnivDatos Market Insights

Medical Polymer Market Report Coverage

Accelerate at a CAGR of over 8%

North America, Europe, APAC, Rest of World

North America to Dominate the Medical Polymer Market

United States, Canada, Germany, United Kingdom, Spain, Italy, France, China, Japan, India, and Australia

SABIC, BASF SE, Celanese Corporation, Evonik Industries AG, Solvay S.A., Arkema S.A., The Lubrizol Corporation, The Ensinger Group, Covestro AG, and Victrex plc

Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; L egal & Regulatory Framework; Demand and Supply Side Analysis; C ompetitive Landscape ; Company Profiling

By Type; By Structure; By Application; By Region/Country

About UnivDatos Market Insights (UMI)

UnivDatos Market Insights (UMI) is a passionate market research firm and a subsidiary of Universal Data Solutions. We believe in delivering insights through Market Intelligence Reports, Customized Business Research, and Primary Research. Our research studies are spread across topics across the world, we cover markets in over 100 countries using smart research techniques and agile methodologies. We offer in-depth studies, detailed analysis, and customized reports that help shape winning business strategies for our clients.

UnivDatos Market Insights Ankita Gupta Director Operations Ph: +91-7838604911 Email: Ankita.gupta@univdatos.com Website: https://univdatos.com/

Logo: https://mma.prnewswire.com/media/1225049/UnivDatos_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/advent-of-3d-printed-devices-and-development-of-patient-specific-implants-to-proliferate-medical-polymer-industry--univdatos-market-insights-301629799.html

SOURCE UnivDatos Market Insights Pvt. Ltd.

On Wednesday, the Fed bumped up interest rates again, its third 75-basis point hike since June, and signaled that there could be two more such hikes by the end of this year. The conventional wisdom has the Fed acting properly, and aggressively, in an attempt to counter inflation raging at 40-year high levels. But conventional wisdom isn’t always right – and we can learn a lot by consulting the contrarians. Few top investors are more contrarian than Cathie Wood. The founder and manager of ARK Inv

KEY WORDS “I think we’re giving Powell too much praise. … The last two years are one of the biggest policy mistakes in the 110-year history of the Fed by staying so easy when everything was booming.

Homeowners beware. But don't panic, either.

And what it means for your wealth-building options.

You have just a few weeks to pounce on Treasury I bonds' sky-high interest rate. Also called Series I savings bonds, their interest rate is 9.62%.

The shipping company has developed a reputation as one of the best dividend stocks around

Boeing (NYSE: BA) made a big move to put part of its troubled past behind it, but the aerospace manufacturer also apparently has fallen out of favor with what had been a key customer in China. Boeing has taken its investors on a turbulent ride over the past few years. The company's 737 MAX, which was once billed as having the potential to be the top-selling aircraft of all time, was involved in fatal crashes in 2018 and 2019 that led to the plane being grounded for 18 months and prompted a comprehensive review of Boeing's engineering and safety practices.

In a year when all three of the major stock indexes in the United States have declined by 15% or more, there are plenty of dividend stocks out there with high dividend yields. What if I told you that there is a Dow Jones Industrial Average stock with a yield north of 6%? Dow Inc. (NYSE: DOW), a maker of various chemical products and one of the Dow Jones Industrial Average's 30 components, fits this description.

Yahoo Finance's Jared Blikre joins the Live show to check out market and sector losses amid today's sell-off, while also looking at meme stocks and the travel industrial.

(Bloomberg) -- Next week’s elections in Brazil pose a challenge to Petrobras investors. Former President Luiz Inacio Lula da Silva, the front-runner, has vowed to use the company as a vehicle for national development. Incumbent Jair Bolsonaro, who’s fighting for a come-from-behind upset, is proposing the complete opposite, with plans to privatize the state-run giant.Most Read from BloombergBank of England Says Paper Banknotes Only Good for One More WeekRisk Assets Crushed With Few Signs Drama Is

Evercore ISI Senior Managing Director Julian Emanuel joins Yahoo Finance Live to discuss the bond market and why investors should turn their attention there if they're turned off by market volatility.

Netflix Inc. is seeking a new chief accounting officer after its current one quit the role after less than four months.

In this article, we discuss 10 best stocks to buy before recession begins. If you want to see more stocks in this selection, click 5 Best Stocks to Buy Before Recession Begins. Between 1929 and 1939, the period famously dubbed the Great Depression, global economies suffered from stock market crashes, sharp declines in output, high […]

While it's undoubtedly challenging to choose between these two wireless titans, both have advantages and disadvantages.

The market has soured on these stocks, but insiders are buying. Is it time to load up on these companies?

Needless to say, this has investors -- especially those looking for dividends -- very interested in energy stocks right now. Two in particular are getting a lot of attention: Chevron (NYSE: CVX) and Enterprise Products Partners (NYSE: EPD). While both Chevron and Enterprise Products are strong companies (I own Enterprise Products, too), there are some characteristics of Phillips 66 that are very compelling.

At a companywide all-hands meeting this week, Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) chief Sundar Pichai juggled tough questions from employees regarding cuts to travel and entertainment budgets, managing productivity, and potential layoffs. Employees questioned why Google is "nickel-and-diming employees" by cutting travel and swag budgets despite record profits and substantial cash reserves as it did after the pandemic. Pichai emphasized acting responsibly to tide through such critical sit

Boise, Idaho; Philadelphia; Pensacola, Fla.; Austin; and Reno, Nev.; Minnesota; and Utah are the housing markets with the most buyer pullback, says one home builder.

Goldman finally decided to stop fighting the Fed and no longer sees the index finishing the year at 4300.

Yes, there's a lot of economic concerns, but this is a buying opportunity (and things aren't nearly as bad as they seem).